Peripheral immune cells and intraoperative radiation in low-risk breast cancer
Por:
Linares, I, Frances, MAB, Canas-Cortes, R, Pujol-Canadell, M, Nunez, M, Anton, SC, Martinez, E, Laplana, M, Perez-Montero, H, Farnos, MJP, Both, B and Guedea, F
Publicada:
1 nov 2020
Resumen:
Filiaciones:
Linares, I:
Inst Invest Biomed Bellvitge IDIBELL, Inst Catala Oncol, Radiobiol & Canc Grp, ONCOBELL Program,Radiat Oncol, Barcelona, Spain
Frances, MAB:
Inst Invest Biomed Bellvitge IDIBELL, Inst Catala Oncol, Radiobiol & Canc Grp, ONCOBELL Program,Radiat Oncol, Barcelona, Spain
Canas-Cortes, R:
Inst Invest Biomed Bellvitge IDIBELL, Radiobiol & Canc Grp, ONCOBELL Program, Barcelona, Spain
Pujol-Canadell, M:
Inst Invest Biomed Bellvitge IDIBELL, Radiobiol & Canc Grp, ONCOBELL Program, Barcelona, Spain
Nunez, M:
Inst Invest Biomed Bellvitge IDIBELL, Inst Catala Oncol, Radiobiol & Canc Grp, ONCOBELL Program,Radiat Oncol, Barcelona, Spain
:
Hosp Badalona Germans Trias & Pujol, Radiat Oncol, Badalona, Spain
:
Inst Catala Oncol, Radiat Oncol, Barcelona, Spain
Laplana, M:
Inst Catala Oncol, Radiat Oncol, Barcelona, Spain
Perez-Montero, H:
Inst Catala Oncol, Radiat Oncol, Barcelona, Spain
Farnos, MJP:
Hosp Univ Bellvitge, Dept Gynecol, Barcelona, Spain
Both, B:
Carl Zeiss Meditec AG, Med Technol Business Grp, ZEISS Grp, Med Affairs & Profess Educ,Business Sect Radiothe, Oberkochen, Germany
Guedea, F:
Inst Invest Biomed Bellvitge IDIBELL, Inst Catala Oncol, Radiobiol & Canc Grp, ONCOBELL Program,Radiat Oncol, Barcelona, Spain
|